New Delhi: In continuation of the allocation plan of Remdesivir drug for the period 21st April to 9th May, the Ministry of Health and Family Welfare has set the company wise supply plan for each state after consulting with the marketing companies and instructed companies to ensure timely supplies to all states/UTs strictly as per the set supply plan.
The companies included in the Government supply plan are Zydus Cadila, Hetero, Mylan, Cipla, Syngene/ Sun, Jubilant, Dr Reddys.
This came, followed by the recent order dated 7th May 2021 providing an updated allocation plan of Remdesivir drug valid for the period 21st April to 16th May, 2021, prepared jointly by the Department of Pharmaceuticals and the Ministry of Health and Family Welfare.
Remdesivir, an adenosine analogue nucleotide prodrug, is a promising therapeutic candidate for Covid-19 which acts by interacting with the viral RNA-dependent RNA polymerase and prevents viral replication by terminating RNA transcription prematurely. With the second wave of Covid, there is a sharp increase in the demand for Remdesivir.
Also Read:AIOCD says Delhi Govt online portal for managing Remdesivir cumbersome, seeks to change process
The previous order dated 7th May, 2021 included
(i) The allotment is being made for the States/UTs, and it is the State Governments and UTs that have to monitor proper distribution within the State/UT, covering government and private hospitals as appropriate and in line with judicious use.
(ii) State Governments/UTs are advised to place adequate purchase orders with the marketing companies immediately, if they have not already done so, for the quantity that they want to purchase out of the allocation for the State/UT as per supply plan in close coordination with the liaison officers of the companies. Coordination with state-owned private distribution channels is also an option.
(iii) Nodal officers of the State Governments have to coordinate and follow up with the marketing companies to get delivery of Remdesivir injection in time as per the daily requirements.
In connection with this, as per the ANI report, on May 7, Union Minister of Chemicals and Fertilizers DV Sadananda Gowda informed that allocation of Remdesivir vials to the states has been made up to May 16 in the wake of the Covid-19 pandemic.
"Considering the requirement of Remdesivir in every state and ensuring its adequate availability, allocation of Remdesivir has been made up to 16th May 2021," Gowda had tweeted.
"This will ensure smooth supply of Remdesivir across the country so that no patient faces difficulty in this pandemic time," he had added.
Gowda had shared an official notification with a list which stated 5,30,0000 vials of Remdesivir have been allocated to the states between April 21 and up to May 16.
In view of the above, the recently issued order stated,
"Please take reference to our DO of even number dated 7t h May, 2021 vide which the allocation plan of Remdesivir drug valid for the period 21s t April to 16t h May, 2021 was issued earlier today. The company-wise supply plan for each state has been prepared in consultation with the marketing companies. The supply plan is attached herewith. The companies have been instructed to ensure timely supplies to all States/UTs strictly as per the supply plan."
As per the order, the supply plan is attached herewith:
Company wise supply plan of Remdesivir vials for period 21s t April to 16t h May, 2021
S No.
State/ UT
Zydus Cadila
Hetero
Mylan
Cipla
Syngene/ Sun
Jubilant
Dr.
Reddys
Total Allocation
1
Andaman and Nicobar Islands
2000
2000
2
Andhra Pradesh
117100
80000
6000
31900
235000
3
Arunachal Pradesh
2000
2000
4
Assam
6000
4800
20000
200
31000
5
Bihar
40000
46000
5200
22300
12000
11500
13000
150000
6
Chandigarh
4000
2500
400
6100
13000
7
Chhattisgarh
44000
68150
30000
33000
1000
13100
10750
200000
8
Dadra and Nagar
Haveli and Daman and Diu
500
3500
4000
9
Delhi
67400
68300
11000
20000
18700
27500
7100
220000
10
Goa
10700
3000
10300
2000
26000
11
Gujarat
286000
74700
27000
8000
14000
5000
4300
419000
12
Haryana
64500
4000
7000
27800
39700
6000
149000
13
Himachal Pradesh
8500
3500
12000
24000
14
Jammu and Kashmir
33000
9000
42000
15
Jharkhand
10000
23400
19500
6000
16000
4100
79000
16
Karnataka
151000
202300
83000
42000
73000
23700
575000
17
Kerala
13300
46000
66000
26000
16700
32000
200000
18
Ladakh
2000
2000
19
Lakshadweep
2000
2000
20
Madhya Pradesh
51000
83000
69300
22000
13000
15000
6700
260000
21
Maharashtra
109800
497000
80000
235600
83500
70300
80800
1157000
22
Manipur
2000
2000
23
Meghalaya
1000
1000
2000
24
Mizoram
2000
2000
25
Nagaland
2000
2000
26
Odisha
10000
14500
1500
29500
7000
2500
8000
73000
27
Puducherry
4000
1900
5100
11000
28
Punjab
4000
30000
2000
14000
8400
17600
9000
85000
29
Rajasthan
55000
53000
42000
54900
10600
22000
10500
248000
30
Sikkim
1500
500
2000
31
Tamil Nadu
36000
69400
72500
5000
10000
3100
9000
205000
32
Telangana
86300
45000
2000
500
11200
145000
33
Tripura
1000
1000
2000
34
Uttarakhand
9500
34900
13500
9500
6600
74000
35
Uttar Pradesh
228300
93600
12000
51200
21900
75000
13000
495000
36
West Bengal
13800
73000
1000
23300
20400
5600
22900
160000
Total
982100
1717050
728000
732300
373000
445700
321850
5300000
Also Read: Monitor Supply Of Drugs Under COVID Treatment Protocol Including Remdesivir, Toclizomab: MHA To States, UTs